Relevance of stroke code, stroke unit and stroke networks in organization of acute stroke care - The Madrid acute stroke care program

Cerebrovascular Diseases

Volumn 27, Issue SUPPL. 1, 2009, Pages 140-147

  Alonso De Leciñana Cases, María ^a   Gil Núñez, Antonio ^a,b   Díez Tejedor, Exuperio ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Acute stroke; Attention chain; Care resources; Medical care; Stroke code; Stroke management; Stroke network

Indexed keywords

AGING; AWARENESS; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISABILITY; EARLY INTERVENTION; EMERGENCY CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INCIDENCE; LIFE EXPECTANCY; LONG TERM CARE; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL STAFF; MORTALITY; NEUROPROTECTION; NURSE PATIENT RATIO; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT TRANSPORT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; REPERFUSION; SECONDARY PREVENTION; SPAIN; STROKE; STROKE UNIT; TREATMENT INDICATION;

EID: 64149108045     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200452     Document Type: Conference Paper

References (55)

1. Bejot Y, Benatru I, Rouaud O, Fromont A, Besancenot JP, Moreau T, Giroud M: Epidemiology of stroke in Europe: geographic and environmental differences. J Neurol Sci 2007;262:85-88.
2. Centers for Disease Control and Prevention (CDC): Prevalence of stroke - United States, 2005. MMWR Morb Mortal Wkly Rep 2007;56:469-474.
3. Pan-American Health Organization: Regional Core Health Data Initiative. Available at www.paho.org/english/dd/ais/coredata.htm.
4. Camargo EC, Bacheschi LA, Massaro AR: Stroke in Latin America. Neuroimaging Clin N A m 2005;15:283-296.
5. Medrano Alberto MJ, Boix Martínez R, Cerrato Crespán E, Ramírez Santa-Pau M: Incidence and prevalence of ischaemic heart disease and cerebrovascular disease in Spain: a systematic review of the literature. Rev Esp Sa lud Publica 2006;80:5-15.
6. Díaz Guzman J, Egido J, Abilleira S, Barberá G, Gabriel R en representación del Grupo Proyecto Ictus (GEECV) de la Sociedad Española de Neurología: Incidencia del ictus en España. Datos preliminares crudos del estudio IBERICTUS. Neurología 2007;22:605.
7. Instituto Nacional de Estadística: Defunciones según la causa de muerte. Encuesta de morbilidad hospitalaria. Available at http://www.ine.es.
8. Gresham GE, Kelly-Hayes M, Wolf PA, et al: Survival and functional status 20 or more years after stroke: the Framingham Study. Stroke 1998;29:793-797.
9. Flynn RW, Macwalter RS, Doney AS: The cost of cerebral ischaemia. Neuropharmacology 2008;55:250-256.
10. Beguiristain JM, Mar J, Aráosla A: Coste de la enfermedad cerebrovascular aguda. Rev Neurol 2005;40:406-411.
11. Carod Artal FJ, Egido Herrero JA, Gonzalez Gutierrez JL, Varela de Seijas E: Coste directo de la enfermedad cerebrovascular en el primer año de seguimiento. Rev Neurol 1999;28:1123-1130.
12. Hacke W, Donan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Tria ls Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
13. Dávalos A, Castillo J, Martinez-Vila E: Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke 1995;26:2233-2237.
14. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. I. Pathophysiology. J Neurosurg 1992;77:169-184.
15. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. II. Mechanisms of damage and treatment. J Neurosurg 1992;77:337-35 4.
16. García JH, Liu KF, Ho KL: Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 1995;26:636-643.
17. Ferrer I: Apoptosis: future targets for neuroprotective strategies. Cerebrovasc Dis 2006; 21(suppl 2):9-20.
18. Castellanos M, Sobrino T, Castillo J: Evolving paradigms for neuroprotection: molecular identification of ischemic penumbra. Cerebrovasc Dis 2006;21(suppl 2):71-79.
19. Lizasoain I, Cárdenas A, Hurtado O, Romera C, Mallolas J, Lorenzo P, Castillo J, Moro MA: Tragets of cytoprotection in acute ischemic stroke: present and future. Cerebrovasc Dis 2006;21(suppl 2):1-8.
20. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF; American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711.
21. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemicstroke. N Engl J Med 1995;333:1581-1587.
22. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grand M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soi n ne L , Ton i D, Va n hooren G ; SI TS -MOST Investigators: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282.
23. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
24. Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, Roine RO, Toni D, Lees KR; SITS Investigators: Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-1309.
25. Mar J, Begiristain JM, Arrazola A: Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis 2005; 20:193-200.
26. Grotta J, Burgin S, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV: Intravenous tissue-type plasminogen activator therapy for ischemic stroke. Houston experience 1996-2000. Arch Neurol 2001; 58:2009-2013.
27. Cocho D, Belvís R, Martí-Fàbregas J, Molina-Porcel L, Díaz-Manera J, Aleu A, Pagonabarraga J, García-Bargo D, Mauri A, Martí-Vilalta JL: Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurolog y 2005;64:719-720.
28. Govan L, Langhorne P, Weir CJ; Stroke Unit Trialists Collaboration: Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care? Further analysis of a systematic review. Stroke 2007;38:2536-2540.
29. Díez-Tejedor E, Fuentes B: Homeostasis as basis of acute stroke treatment: stroke units are the key. Cerebrovasc Dis 2005;20(suppl 2):129-134.
30. Seenan P, Long M, Langhorne P: Stroke units in their natural habitat: systematic review of observational studies. Stroke 2007;38:1886-1892.
31. Fuentes B, Diez-Tejedor E, Ortega-Casarrubios M A, Martinez P, Lara M, Frank A: Consistency of the benefits of stroke units over years of operation: an 8-year effectiveness ana lysis. Cerebrovasc Dis 2006;21:173-179.
32. Gil Núñez A, Vivancos Mora J: Organization of medical care in acute stroke. The importance of a good network. Cerebrovasc Dis 2004;17(suppl 1):113-123.
33. Leys D, Ringelstein EB, Kaste M, Hacke W; Executive Committee of the European Stroke Initiative: Facilities available in European hospitals treating stroke patients. Stroke 2007;38:2985-2991.
34. Segura T, Vega G, López S, Rubio F, Castillo J: Public perception of stroke in Spain. Cerebrovasc Dis 2003;16:21-26.
35. Becker K, Fruin M, Gooding T, Tirschwell D, Love P, Mankowski T: Community-based e ducation improves stroke knowledge. Cerebrovasc Dis 2001; 11:34-43.
36. Belvis R, Cocho D, Martí-Fábregas J, Pagonabarraga J, Aleu A, García-Bargo MD, et al: Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year clinical practice in Barcelona, Spain. Cerebrovasc Dis 2005;19:96-101.
37. Álvarez-Sabín J, Molina CA, Abilleira S, Montáner J, García Alfranca F, Jiménez-Fa-brega X, et al: Impacto del código ictus en la eficacia del tratamiento trombolítico. Med Clin (Barc) 2003;120:47-51.
38. Gómez CR, Malkoff MD, Sauer CM, Tulyapronchote R, Burch CM, Banet GA: Code Stroke. An attempt to shorten inhospital therapeutic delays. Stroke 1994;25:1920-1923.
39. Zarz a B, Alonso de Leciñana M, García-Bar-ragán N, Díaz-Sánchez M, López-Sendón J, Cruz-Culebras A, Masjuán J: Influence of the experience and of out-of-hospital stroke code in thrombolytic treatment of acute stroke. Neurologia 2008;23:349-355.
40. Organización de la asistencia en fase aguda del ictus: Unidades de ictus. Recomendacio-nes 2003 del Grupo de Estudio de Enferme-dades Cerebrovasculares de la Sociedad Española de Neurología. Gil Núñez A (coordinador). Madrid, EMISA, 2003.
41. Stroke Unit Trialists' Collaboration: Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007;4:CD000197.
42. Díez-Tejedor E, Fuentes B: Acute care in stroke: do stroke units make the difference? Cerebrovasc Dis 2001;11(suppl 1):31-39.
43. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RAL, Donan GA: Stroke units, tissue plasminogen activator, and neuroprotection: which stroke intervention could provide the greatest community benefit? Cerebrovasc Dis 2005;20:239-244.
44. Fuentes B, Díez Tejedor E: Unidades de ictus. Una necesidad asistencial coste-efectiva. Neurología 2007;22:456-466.
45. Kalra L, Evans A, Perez I, Knapp M, Donaldson N, Swift CG: Alternative strategies for stroke care: a prospective randomised controlled study of stroke unit, stroke team and domiciliary management of stroke. Lancet 2000;356:894-899.
46. Alvarez Sabín J, Alonso de Leciñana M, Gállego J, Gil-Peralta A, Casado I, Castillo J, Díez Tejedor E, Gil A, Jiménez C, Lago A, Martínez-Vila E, Ortega A, Rebollo M, Rubio F; Grupo de Estudio de las Enfermedades Cerebrovasculares de la Sociedad Española de Neurología: Plan for stroke healthcare delivery. Neurologia 2006;21:717-726.
47. Aboderin I, Venables G, Asplund K: Stroke management in Europe. J Intern Med 1996; 240:173-180.
48. Kjellström T, Norrving B, Shatchkute A: Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis 2007; 23:231-241.
49. Canadian Stroke Network and the Heart and Stroke Foundation of Canada: Canadian Stroke Strategy. Canadian Best Practice Recommendations for Stroke Care. Ottawa, Canadian Stroke Network, 2006.
50. Alberta Stroke Council: Alberta provincial stroke strategy. Improving stroke care-making a difference. Alberta, March 26,2007;available at www.strokestrategy.ab.ca.
51. Department of Health: Vascular Program. Stroke Team. A new ambition for stroke: a consultation on a national strategy. London, July 2007; available at www.dh.gov.uk/stroke.
52. Díez Tejedor E, Fuentes B, Rodriguez-Balo A, Alonso de Leciñana M, Egido J, Gil-Nuñez A, Sánchez C, Vivancos J, Matías-Guiu J, Soria MA: Advantages of a Special Stroke Assistance Network. Madrid Acute Stroke Program. Cerebrovasc Dis 2008;25(suppl 2):189.
53. Gil Núñez A: Análisis y estrategia organizativa de la atención neurológica del ictus agudo en la Comunidad de Madrid; tesis doctoral. Madrid, Universidad Autónoma de Madrid, 2008.
54. Vivancos J, Gil Núñez A (Coordinadores): Samur-Protección Civil. Servicio de Urgencias Médicas de Madrid-SUMMA 112-Sociedad Española de Medicina de Urgencias y Emergencias, Agrupación Madrid. Foro de Ictus de Madrid, Asociación Madrileña de Neurología (Comité de redacción). Protocolo de Consenso para la Atención al Ictus en Fase Aguda en la Comunidad de Madrid. Madrid, Ferrer Internacional, 2006.
55. Díez Tejedor E, Egido Herrero JA, Gil Núñez A, Matías Guiu Guía J, Alonso de Leciñana M, Sánchez Sánchez C, Vivancos Mora J, Soria Milla MA, Rodríguez Balo A: En nombre del Foro de Ictus de la Asociación Madrileña de Neurología, y la Dirección General del Servicio Madrileño de Salud - Subdirección General de Atención Especializada. Plan Asistencial del Ictus en la Comunidad de Madrid. Madrid, Consejería de Sanidad de la Comunidad de Madrid, 2008, in press.